Published in Adv Chronic Kidney Dis on September 01, 2015
Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol (2016) 0.75
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int (2002) 8.03
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis (2002) 6.52
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
Disparities in liver transplantation before and after introduction of the MELD score. JAMA (2008) 4.10
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis (2004) 3.35
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Estimating kidney function in adults using formulae. Ann Clin Biochem (2005) 3.28
Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem (2005) 3.10
Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem (2002) 2.88
Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant (2006) 2.53
Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am J Transplant (2005) 2.46
Serum creatinine and renal function. Annu Rev Med (1988) 2.28
The evaluation of renal function and disease in patients with cirrhosis. J Hepatol (2010) 2.10
RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. Am J Med (1965) 2.05
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89
Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl (2007) 1.87
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem (1986) 1.79
OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant (2015) 1.79
Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med (2005) 1.77
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology (1988) 1.76
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis (1976) 1.59
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol (2001) 1.49
Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chim Acta (2004) 1.48
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg (2006) 1.36
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation (2008) 1.35
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol (2003) 1.34
Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis (2000) 1.29
Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25
Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant (2005) 1.20
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology (2013) 1.18
Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med (2002) 1.18
Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut (2002) 1.17
The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant (2005) 1.16
Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology (2014) 1.14
Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl (2000) 1.14
Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int (2009) 1.12
Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant (2005) 1.09
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology (1994) 1.02
Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis (2011) 1.01
Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med (2007) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant (2010) 0.99
The effect of changing serum osmolality on the release of antidiuretic hormone in certain patients with decompensated cirrhosis of the liver and low serum osmolality. J Clin Invest (1959) 0.96
New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab (1989) 0.96
Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Hepatology (1998) 0.95
Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol (2001) 0.92
Altered permeability in the proximal tubule response to cyclic AMP. Am J Physiol (1979) 0.91
Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites. Intensive Care Med (2008) 0.88
Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation. Hepatology (2014) 0.87
Renal hemodynamics and limitations of creatinine clearance in determining filtration rate in glomerular disease. Scand J Urol Nephrol (1971) 0.87
Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer. J Clin Lab Anal (2003) 0.87
Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate. Pediatr Nephrol (2005) 0.86
Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology (1992) 0.85
Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis. Am J Transplant (2014) 0.82
The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin (2012) 0.82
Disparities in liver transplantation in the post-model for end-stage liver disease era: are we there yet? Hepatology (2009) 0.82
Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients. Pediatr Transplant (2005) 0.79
Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime? Liver Transpl (2015) 0.79
Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation (2007) 0.78
Renal support during liver transplantation: when to consider it? Transplant Proc (2013) 0.77
How to evaluate whether a new technology in the operating room is cost-effective from society's viewpoint. Anesthesiol Clin (2008) 0.77
Heterogeneity in liver allocation. Liver Transpl (2004) 0.76
Bilirubin interference in kinetic creatinine determination. Clin Chem (1979) 0.76
The 24 hour urine creatinine clearance for prediction of glomerular filtration rate in liver cirrhosis patients: have we considered all elements? Hepat Mon (2013) 0.76
The role of intraoperative hemodialysis in liver transplant patients. Curr Opin Organ Transplant (2011) 0.76